US equities |
SPCX $167.66 ▲+5.47% NVDA $237.32 ▲+1.44% MU $1,068.63 ▼-0.58% TSLA $376.49 ▲+1.59% MSFT $526.14 ▲+1.66% INTC $117.05 ▼-1.91% SNDK $1,725.40 ▲+0.31% META $745.06 ▲+2.33%
FinancialContent

Niki BioSolutions, Inc. - Common Stock (NQ:NIKI)

4.790 +0.190 (+4.13%)
Delayed Quote Updated: 10:53 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Niki BioSolutions, Inc. - Common Stock

News headline image
Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference
From Niki BioSolutions, Inc.
Via GlobeNewswire
News headline image
Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
From Niki BioSolutions, Inc.
Via GlobeNewswire
News headline image
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
From Niki BioSolutions, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology... 
Via Benzinga
News headline image
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)
From Niki BioSolutions, Inc.
Via GlobeNewswire